EP Patent

EP0870768A1 — Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents

Assigned to Pfizer Inc · Expires 1998-10-14 · 28y expired

What this patent protects

Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH 2 NR 1 R 2 , b) or; c) and R,R 1 and R 2 are independently selected from hydrogen and C 1 -C 6 alkyl; R 3 is selected…

USPTO Abstract

Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. wherein X is: a) -CH 2 NR 1 R 2 , b) or; c) and R,R 1 and R 2 are independently selected from hydrogen and C 1 -C 6 alkyl; R 3 is selected from hydrogen, halogen and C 1 -C 6 alkyl; l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0870768A1
Jurisdiction
EP
Classification
—
Expires
1998-10-14
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.